Julie McHugh joins ViroPharma board
This article was originally published in Scrip
Rare-disease focused biopharmaceutical company ViroPharma has appointed Julie McHugh to its board of directors. Ms McHugh is currently chief operating officer of Endo Pharmaceuticals, and was previously CEO of Nora Therapeutics. She is also on the board of directors of the Biotechnology Industry Organization (BIO), the New England Health Institute and the Nathaniel Adamaczyk Foundation.